| Literature DB >> 26372347 |
Vaea Richard1, Jérôme Viallon1, Van-Mai Cao-Lormeau1.
Abstract
Dengue virus (DENV) is an arbovirus transmitted to humans by the bite of infected Aedes mosquitoes. Experimental per os infection of mosquitoes with DENV is usually a preliminary step in virus/vector studies but it requires being able to prepare artificial blood-meals with high virus titers. We report here the convenient use of centrifugal filter devices to quickly concentrate DENV particles in cell-culture supernatants. The median viral titer in concentrated-supernatants was 8.50 log10 TCID50/mL. By using these DENV concentrated-supernatants to prepare infectious blood-meals in Aedes aegypti per os infection experiments, we obtained a mean mosquito-infection rate of 94%. We also evaluated the use of centrifugal filter devices to recover DENV particles from non-infectious blood-meals presented to infected mosquitoes through a feeding membrane to collect their saliva.Entities:
Mesh:
Year: 2015 PMID: 26372347 PMCID: PMC4570664 DOI: 10.1371/journal.pone.0138161
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effect of using centrifugal filter device on DENV titers in C6/36 cell-culture supernatants.
DENV titers in C6/36 cell-culture supernatants were evaluated before and after concentration with Centricon Plus-70 centrifugal filter devices (CFD; Millipore, Germany). Viral titers were significantly higher after CFD concentration (Paired t-test, P = 0.0001) with an evolution of the median titer (line) from 6.00 to 8.50 log10 TCID50/mL. DENV = Dengue virus.
Infected Aedes aegypti rate (%) at 14 days post-intake of an artificial infectious blood-meal prepared either with initial (trial 1a) or CFD-concentrated DENV supernatants (trials 1b-8).
| Experimental assay | DENV titer in blood meals (log10 TCID50 /mL) | % of infected mosquitoes (N) | DENV RNA load in saliva retentates (log10 copies /μL) |
|---|---|---|---|
| Trial 1a | 5.40 | 38.89 (18) | - |
| Trial 1b | 6.92 | 92.86 (42) | - |
| Trial 2 | 7.02 | 86.67 (30) | - |
| Trial 3 | 8.64 | 90 (20) | - |
| Trial 4 | 8.89 | 100 (27) | - |
| Trial 5 | 8.89 | 100 (37) | - |
| Trial 6 | 7.92 | 95.56 (45) | 4.26 |
| Trial 7 | 7.92 | 91.07 (56) | 4.42 |
| Trial 8 | 7.92 | 98.65 (74) | 5.13 |